Gastrectomy

Subscribe to Selected New Research on Gastrectomy

7426 relevant articles (221 outcomes, 581 trials/studies) found for this Therapy

Description: Excision of the whole (total gastrectomy) or part (subtotal gastrectomy, partial gastrectomy, gastric resection) of the stomach. (Dorland, 28th ed)

Also Known As:

Gastrectomies

Relationship Network

Therapy Context: Research Results

Operative Surgical Procedures: 4

Digestive System Surgical Procedures: 10

Gastrectomy: 7426

Experts

1.	Kitano, Seigo: 10 articles (11/2007 - 01/2002)
2.	Shiraishi, Norio: 9 articles (11/2007 - 01/2002)
3.	Osugi, Harushi: 8 articles (07/2008 - 12/2002)
4.	Kunisaki, Chikara: 8 articles (06/2008 - 01/2003)
5.	Kitano, S: 8 articles (12/2007 - 02/2000)
6.	Takemura, Masashi: 7 articles (07/2008 - 12/2002)
7.	Shimada, Hiroshi: 7 articles (06/2008 - 03/2003)
8.	Shiraishi, N: 7 articles (12/2007 - 07/2000)
9.	Tomita, Ryouichi: 7 articles (11/2006 - 02/2003)
10.	Fujisaki, Shigeru: 7 articles (11/2006 - 02/2003)

Related Diseases

1.	Stomach Neoplasms (Stomach Cancer) 01/01/1985 - "For stage I and II gastric cancer, radical gastrectomy and postoperative immunotherapy for 3 months would be the best treatment." 11/01/2007 - "OBJECTIVES: This study was conducted to determine whether laparoscopy-assisted distal gastrectomy (LADG) with complete D2 lymph node dissection for gastric cancer is a safe and effective surgical option" 07/01/2008 - "CONCLUSION: In advanced gastric cancer patients with non-curative factors, gastrectomy was beneficial for survival with longer maintenance of oral intake." 01/01/2008 - "Advanced gastric cancer is not controlled by surgery alone, although early gastric cancer can be cured by curative gastrectomy" 06/01/2006 - "Although the very high locoregional recurrence rates reported with limited D0/D1 surgery can be reduced with extended D2 gastrectomy for operable gastric cancer, overall relapse and survival rates remain poor and can only be improved with adequate perioperative adjuvant treatment" Order ALL the reference details at left...
2.	Neoplasms (Cancer) 11/01/1994 - "Subtotal gastrectomy in distally located tumors seems to be the best option" 04/28/2008 - "CONCLUSION: IT-ESD appears to be an effective treatment for gastric remnant cancer post distal gastrectomy because of its high CR rate" 04/01/2005 - "CONCLUSION: High-volume providers have a significantly better outcome for complex cancer surgery, specifically for pancreatectomy, oesphagectomy, gastrectomy and rectal resection." 04/01/2001 - "This series shows that laparoscopic radical gastrectomy for moderately advanced cancers can produce good results in terms of safety and oncologic adequacy." 01/01/1994 - "Patients with a pouch judge their postoperative individual state better than patients with simple jejunostomy indicated with an on average symptom related score note better than 3. As long as the tumor stage is associated with a beneficial prognosis and the tumor localisation allows the reconstruction by an esophagojejunoplication the formation of a pouch after total gastrectomy is recommended because of an improved transit pattern and clinical course." Order ALL the reference details at left...
3.	Carcinoma (Carcinomatosis) 10/01/1999 - "The determination of the expression of TP might be useful for predicting the efficacy of post-operative chemotherapy using FUs to prevent recurrence in advanced gastric carcinoma patients who undergo curative gastrectomy." 11/01/1991 - "A retrospective study of 1,704 consecutive cases of gastric carcinomas showed a better outcome following total gastrectomy in relationship to distal subtotal gastrectomy, but these results cannot be used as evidence because of the lack of a prospective study" 12/01/2002 - "We included randomized and quasi-randomized trials comparing the efficacy of intravenous chemotherapy after gastrectomy with that of surgery alone in patients with confirmed gastric carcinomas who had undergone gastrectomy" 03/01/2008 - "Efficacy of prophylactic extended lymphadenectomy with gastrectomy for patients with node-negative advanced gastric carcinoma." 12/01/2002 - "AIM: To assess the safety and efficacy of different intravenous chemotherapeutic regimens in patients with gastric carcinomas who had undergone gastrectomy" Order ALL the reference details at left...
4.	Neoplasm Metastasis (Metastasis) 09/01/2000 - "CONCLUSION: The results of the present study have suggested that radical gastrectomy combined with lymphadenectomy is essential to achieve complete remission in patients with lymph node metastasis restricted to perigastric nodes" 02/01/2002 - "Among 11 patients with lymph node metastasis only after a curative gastrectomy, there was an 82% objective response rates with 27% having complete remission and 55% having partial response" 01/01/2001 - "CONCLUSIONS: Palliative gastrectomy compared to unresectable operation may be effective for improvement of prognosis even if stage IVb patients with peritoneal dissemination and/or distant lymph node metastasis" 09/01/2002 - "BACKGROUND/AIMS: It is necessary to study the relation between lymph node metastasis in the suprapyloric or lesser curvature regions and clinicopathologic findings in order to determine the indications for pylorus-preserving gastrectomy" 04/01/1999 - "CONCLUSIONS: This study suggests that the risk of ovarian metastasis after curative gastrectomy is strongly associated with the number of metastatic lymph nodes (>6) and patient age (<50 years)" Order ALL the reference details at left...
5.	Ulcer 07/01/1983 - "When remedial surgery for recurrent ulcer consisted of vagotomy and distal subtotal gastrectomy (35 patients) after previous vagotomy and drainage procedure (21 patients), subtotal gastrectomy (three patients), vagotomy and hemigastrectomy (eight patients), or gastroenterostomy alone (three patients), there were no operative deaths, 74% of 27 patients available for at least a 5-year follow-up had excellent or good results, and rerecurrent ulceration developed in only one patient" 01/01/1979 - "As between the various forms of operation, truncal vagotomy and antrectomy and subtotal gastrectomy demonstrated significantly better protection against proven recurrent ulcer than did truncal vagotomy and pyloroplasty (p less than 0.05)" 08/26/1982 - "We conclude that substituting highly selective vagotomy for gastrectomy will not lead to improved survival, because 80 per cent of patients now having operations for ulcer are heavy cigarette smokers." 09/01/1984 - "Why I was attracted by ulcer surgery, Experimental studies on gastroenterostomy and ulcer, Topography and extent of gastrectomy, advocation of the dual control mechanism theory, and My association with vagotomy." 07/01/1983 - "In the present study the authors report on the results obtained with the use of fiberoptic endoscopy complemented by biopsy of the mucosa of the duodenal stump for the diagnosis of retained gastric antrum in recurrent ulcer following B-II type gastrectomy" Order ALL the reference details at left...

Related Drugs and Biologics

1.	Fluorouracil (Carac)
2.	Proton Pumps (Proton Pump)
3.	Cimetidine (Biomet)
4.	Omeprazole (Esomeprazole)
5.	Gastrins
6.	Calcium
7.	Mitomycin (Mitomycin-C)
8.	Glucose (Dextrose)
9.	Biological Tumor Markers (Tumor Markers)
10.	Cholecalciferol (Vitamin D3)

Related Therapies and Procedures

1.	Lymph Node Excision (Lymph Node Dissection)
2.	Drug Therapy (Chemotherapy)
3.	Vagotomy
4.	Gastroenterostomy
5.	Gastric Bypass (Roux-en-Y Gastric Bypass)

Best Treatments:
Research Summary Report
on Stomach Neoplasms

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 815 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>